Skip to main content

The Top Four Antitrust Enforcement Issues in Healthcare Today

Antitrust and Competition Law Alert® | September 13, 2023

Recent enforcement efforts by the DOJ and FTC show that the healthcare sector is under heightened scrutiny from US competition authorities. In 2021, the Biden administration issued an Executive Order on Promoting Competition in the American Economy, which directed federal agencies to take a number of steps to address perceived competitive harm occurring in the sector. Against this backdrop, here are the top four antitrust issues currently impacting the healthcare industry:

  • Heightened Scrutiny of Healthcare M&A
  • Reassessing Prior Positions on Prescription Drug Price Transparency and Vertical Integration 
  • Labor Market Competition Enforcement: Non-Competes and No-Poach Agreements
  • Heightened Scrutiny of Information Sharing Between Competitors

Click below to read "The Top Four Antitrust Enforcement Issues in Healthcare Today." For more information, contact our authors Richard Powers, Barry Nigro, Nathaniel Asker or Aleksandr Livshits

Additional Information

View PDF

This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.